What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.46%Below 5Y avg (2.69%)
Annual Rate
CNY 0.25Paid annual
Payout Ratio
83.3%Moderate
Payback Period
41.2 yr
Last Ex-Dividend
May 22, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.25BCNY
630.80M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
17.87x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Revenue (TTM)
3.13BCNY
465.48M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
8.04%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Beta
0.6450x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-20.90%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
4.25BCNY
630.80M · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
3.63BCNY
539.14M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
17.87x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Forward P/E
10.31x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Price to Sales (TTM)
1.43x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 1.36×.Updated Aug 19, 2026
Price to Book (MRQ)
1.01x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Enterprise to Revenue
1.16x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Enterprise to EBITDA
10.02x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 12.56×.Updated Aug 19, 2026
Gross Margin
35.60%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Profit Margin
8.04%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Operating Margin
4.76%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Return on Assets (TTM)
2.25%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Return on Equity (TTM)
5.59%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Revenue (TTM)
3.13BCNY
465.48M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
7.42CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
-13.20%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Gross Profit (TTM)
1.16BCNY
172.98M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
288.94MCNY
42.91M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
251.92MCNY
37.41M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
-32.00%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
678.03MCNY
100.70M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
293.64MCNY
43.61M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing Annual Dividend Rate
0.2500CNYUpdated Aug 19, 2026
Trailing Annual Dividend Yield
2.46%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
2.69%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
83.33%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 41.67%.Updated Aug 19, 2026
Minority Interest (Equity)
4.82KCNYFY2025 · Dec 31, 2025
Revenue
3.23BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.03BCNYFY2025 · Dec 31, 2025
Gross Profit
1.20BCNYFY2025 · Dec 31, 2025
Operating Income
311.51MCNY
46.27M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
301.88MCNYFY2025 · Dec 31, 2025
Income Tax Expense
35.98MCNYFY2025 · Dec 31, 2025
Net Income
265.90MCNYFY2025 · Dec 31, 2025
EBIT
313.31MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
438.33MCNYFY2025 · Dec 31, 2025
Research & Development
238.79MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
428.20MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
28.01MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
16.18MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
11.43MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.6400CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.6400CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
415.48MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
415.48MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
265.90MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
729.00CNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-18.93MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-172.74MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.18BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
265.90MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
16.80MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-215.90MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-85.74MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-153.81MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-508.96MCNYFY2025 · Dec 31, 2025
Sale of Investments
851.05MCNYFY2025 · Dec 31, 2025
Other Investing Activity
1.14MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
189.42MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
57.42MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-49.74MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-221.77MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-96.20MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-310.29MCNYFY2025 · Dec 31, 2025
Shares Outstanding
417.21MSharesUpdated Aug 19, 2026
Float Shares
238.20MSharesUpdated Aug 19, 2026
% Held by Insiders
46.61%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
0.40%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
1.31BCNY
194.09M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
3.08CNYUpdated Aug 19, 2026
Total Debt (MRQ)
385.80MCNY
57.30M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.0852x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Current Ratio (MRQ)
1.86x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
10.67CNYUpdated Aug 19, 2026
Total Assets
7.51BCNY
1.12B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
4.72BCNYFY2025 · Dec 31, 2025
Total Liabilities
3.01BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.79BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
495.20MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
2.52BCNYFY2025 · Dec 31, 2025
Cash
1.16BCNYFY2025 · Dec 31, 2025
Cash Equivalents
32.64MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.19BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
335.61MCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.91BCNYFY2025 · Dec 31, 2025
Inventory
622.85MCNYFY2025 · Dec 31, 2025
Accounts Payable
2.02BCNYFY2025 · Dec 31, 2025
Short-term Debt
85.37MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
11.05MCNYFY2025 · Dec 31, 2025
Long-term Debt
322.71MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
85.26MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
417.21MCNYFY2025 · Dec 31, 2025
Retained Earnings
2.07BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
4.50BCNY
668.07M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
9.39CNYUpdated Aug 19, 2026
52-Week High
21.28CNYUpdated Aug 19, 2026
52-Week Change
-20.90%
vs all stocks
Updated Aug 19, 2026
Beta
0.6450x
vs all stocks
Updated Aug 19, 2026
50-Day MA
10.73CNYUpdated Aug 19, 2026
200-Day MA
13.93CNYUpdated Aug 19, 2026
Avg 10-Day Volume
9.25MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
7.38MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
0.6000CNYUpdated Aug 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 1.01×, lower than 95% of its Scientific & Technical Instruments peers (median 3.34×)Notable